AlRasheed, H.A.; El-Haggar, S.M.; Hegazy, S.K.; Maher, M.M.; Bahgat, M.M.; Bahaa, M.M.
Repurposing Atorvastatin, HMGCO-A Reductase Inhibitor, in Patients with Ulcerative Colitis: A Randomized Controlled Study. J. Clin. Med. 2025, 14, 3077.
https://doi.org/10.3390/jcm14093077
AMA Style
AlRasheed HA, El-Haggar SM, Hegazy SK, Maher MM, Bahgat MM, Bahaa MM.
Repurposing Atorvastatin, HMGCO-A Reductase Inhibitor, in Patients with Ulcerative Colitis: A Randomized Controlled Study. Journal of Clinical Medicine. 2025; 14(9):3077.
https://doi.org/10.3390/jcm14093077
Chicago/Turabian Style
AlRasheed, Hayam Ali, Sahar M. El-Haggar, Sahar K. Hegazy, Maha M. Maher, Monir M. Bahgat, and Mostafa M. Bahaa.
2025. "Repurposing Atorvastatin, HMGCO-A Reductase Inhibitor, in Patients with Ulcerative Colitis: A Randomized Controlled Study" Journal of Clinical Medicine 14, no. 9: 3077.
https://doi.org/10.3390/jcm14093077
APA Style
AlRasheed, H. A., El-Haggar, S. M., Hegazy, S. K., Maher, M. M., Bahgat, M. M., & Bahaa, M. M.
(2025). Repurposing Atorvastatin, HMGCO-A Reductase Inhibitor, in Patients with Ulcerative Colitis: A Randomized Controlled Study. Journal of Clinical Medicine, 14(9), 3077.
https://doi.org/10.3390/jcm14093077